Cordyceps Sunshine Biotech Holdings (RAJAF) Current Assets (2020 - 2025)

Cordyceps Sunshine Biotech Holdings' Current Assets history runs 6 years deep, the most recent figure standing at $997742.0 for Q4 2025.

• In Q4 2025, Current Assets rose 65.85% year-over-year to $997742.0; the TTM figure through Dec 2025 stood at $997742.0 (up 65.85% YoY), while the FY2025 annual figure was $997742.0, up 65.85% from the prior year.
• Current Assets was $997742.0 for Q4 2025 at Cordyceps Sunshine Biotech Holdings, up from $601602.0 in the prior quarter.
• In the past five years, Current Assets ranged from a high of $1.1 million in Q4 2021 to a low of $52135.0 in Q3 2023.
• Historically, Current Assets has averaged $601839.0 across 5 years, with a median of $551577.0 in 2022.
• The sharpest annual moves came in 2022 and 2024: Current Assets plunged 55.65% in 2022, then surged 83.88% in 2024.
• A 5-year view of Current Assets shows it stood at $1.1 million in 2021, then slumped by 55.65% to $501552.0 in 2022, then plunged by 34.77% to $327175.0 in 2023, then jumped by 83.88% to $601602.0 in 2024, then soared by 65.85% to $997742.0 in 2025.
• The last three Current Assets figures came in at $997742.0 (Q4 2025), $601602.0 (Q4 2024), and $327175.0 (Q4 2023), per Business Quant data.